These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35215919)

  • 1. Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines.
    Bamford CGG; Broadbent L; Aranday-Cortes E; McCabe M; McKenna J; Courtney DG; Touzelet O; Ali A; Roberts G; Lopez Campos G; Simpson D; McCaughey C; Fairley D; Mills K; Power UF; On Behalf Of The Breathing Together Investigators
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.
    Zou W; Xiong M; Hao S; Zhang EY; Baumlin N; Kim MD; Salathe M; Yan Z; Qiu J
    mBio; 2021 May; 12(3):. PubMed ID: 33975939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells.
    Aiewsakun P; Phumiphanjarphak W; Ludowyke N; Purwono PB; Manopwisedjaroen S; Srisaowakarn C; Ekronarongchai S; Suksatu A; Yuvaniyama J; Thitithanyanont A
    Genome Biol Evol; 2023 Apr; 15(4):. PubMed ID: 36852863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike.
    Baczenas JJ; Andersen H; Rashid S; Yarmosh D; Puthuveetil N; Parker M; Bradford R; Florence C; Stemple KJ; Lewis MG; O'Connor SL
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
    Sasaki M; Uemura K; Sato A; Toba S; Sanaki T; Maenaka K; Hall WW; Orba Y; Sawa H
    PLoS Pathog; 2021 Jan; 17(1):e1009233. PubMed ID: 33476327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    Pohl MO; Busnadiego I; Kufner V; Glas I; Karakus U; Schmutz S; Zaheri M; Abela I; Trkola A; Huber M; Stertz S; Hale BG
    PLoS Biol; 2021 Mar; 19(3):e3001006. PubMed ID: 33760807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia.
    Meganck RM; Edwards CE; Mallory ML; Lee RE; Dang H; Bailey AB; Wykoff JA; Gallant SC; Zhu DR; Yount BL; Kato T; Shaffer KM; Nakano S; Cawley AM; Sontake V; Wang JR; Hagan RS; Miller MB; Tata PR; Randell SH; Tse LV; Ehre C; Okuda K; Boucher RC; Baric RS
    Cell Rep; 2024 Apr; 43(4):114076. PubMed ID: 38607917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models.
    Mautner L; Hoyos M; Dangel A; Berger C; Ehrhardt A; Baiker A
    Virol J; 2022 Apr; 19(1):76. PubMed ID: 35473640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells.
    de Souza GAP; Le Bideau M; Boschi C; Ferreira L; Wurtz N; Devaux C; Colson P; La Scola B
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.
    Touret F; Luciani L; Baronti C; Cochin M; Driouich JS; Gilles M; Thirion L; Nougairède A; de Lamballerie X
    mBio; 2021 Aug; 12(4):e0085021. PubMed ID: 34225487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003.
    Vega VB; Ruan Y; Liu J; Lee WH; Wei CL; Se-Thoe SY; Tang KF; Zhang T; Kolatkar PR; Ooi EE; Ling AE; Stanton LW; Long PM; Liu ET
    BMC Infect Dis; 2004 Sep; 4():32. PubMed ID: 15347429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected
    Rowe LA; Beddingfield BJ; Goff K; Killeen SZ; Chirichella NR; Melton A; Roy CJ; Maness NJ
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
    Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS
    Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
    Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
    J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.